Results: 555

Characterization of Lactobacillus fermentum UCO-979C, a probiotic strain with a potent anti-Helicobacter pylori activity

Background: Helicobacter pylori is considered as the main risk factor in the development of gastric cancer. In the present study, we performed a detailed characterization of the probiotic properties and the anti-H. pylori activity of a previously isolated lactobacillus strain — Lactobacillus fermentum ...

Genomics and epidemiology for gastric adenocarcinomas

Appl. cancer res; 37 (), 2017
Whereas the pathological aspects of Gastric Adenocarcinomas (GACs) have been well defined, the actual knowledge of its genesis and evolution remains to be translated to better diagnosis and to more effective therapeutics. As a consequence, the current treatment modalities are not yet able to modify the n...

Expression of the c-MET, HGF and VEGF biomarkers in intestinal and diffuse gastric cancer in the Brazilian population: a pilot study for the standardization of the quantitative PCR technique

Appl. cancer res; 37 (), 2017
Background: Gastric carcinoma (GC) is the third leading cause of death among malignant tumors worldwide, causing approximately 900,000 deaths/year. Changes in oncogenes that encode tyrosine kinase receptors play an important role in the pathogenesis of GC. MET gene is a proto-oncogene that encodes a tyro...

Intususcepción intestinal debido a un pólipo fibroide inflamatorio (tumor de vanek)

Rev. Nac. (Itauguá); 9 (2), 2017
La intususcepción en un adulto debe hacer sospechar un tumor (benigno o potencialmente riesgoso); el diagnóstico certero es crucial para el tratamiento adecuado del paciente1. Alrededor del 90% de estos casos se dan en el intestino delgado y colon, el 10% restante se originan en el estómago y en esto...

Intervening factors for the initiation of treatment of patients with stomach and colorectal cancer

ABSTRACT Objective: to identify the time between symptoms, the request for care and the beginning of treatment in patients with stomach and colorectal cancer as well as the factors that interfere in these processes. Method: correlational descriptive study, including 101 patients diagnosed with stomach ...

Eficacia de terapia concomitante sin bismuto en la erradicación de Helicobacter pylori en Chile: estudio prospectivo

Gastroenterol. latinoam; 28 (3), 2017
Standard triple therapy (TT), used massively as first-line empirical therapy for Helicobacter pylori (H. pylori) eradication, has shown a progressive decrease in its effectiveness, probably due to increasing resistance to clarithromycin. Recent studies in Chile show eradication under 90%, a limit suggest...

Causa infrecuente de dispepsia

Gastroenterol. latinoam; 28 (4), 2017

¿Por qué no diagnosticamos el cáncer gástrico incipiente? ¿Cómo podemos mejorar?

Gastroenterol. latinoam; 28 (supl.1), 2017
Detection and treatment of gastric cancer (GC) in early stages is the most effective approach for improving prognosis. Patients with early gastric cancer (EGC), defined as a type of cancer affecting only mucosa and submucosa, has a good prognosis in the long-term, and if some criteria are met, endoscopic...

Câncer gástrico

Objetivos: Revisão do processo diagnóstico, estadiamento, conduta terapêutica e seguimento do paciente com câncer (CA) de estômago. Métodos: selecionados artigos relevantes dos últimos 5 anos sobre a terapêutica do CA gástrico. Resultados: Sintomas e achados no exame físico do paciente com CA d...